Table 1.
Clinical and biochemical data of examined patients
| Parameter | Mean ± SDa |
|---|---|
| Age (years) | 50.46±10.88 |
| Gender: female/male (n) | 27/202 |
| Alcohol abuse: yes/no (n) | 91/138 |
| Cirrhosis: yes/no (n) | 217/12 |
| HBsAg: positive/negative (n) | 191/38 |
| Tumor size (range, cm) | 7.28±3.93 |
| AFP (ng/mL): median, range | 123.4 (0.23–38,030.00) |
| WBC (×109/L) | 6.47±2.13 |
| LYMPH (×109/L) | 1.74±0.66 |
| Platelets (×109/L) | 189.75±80.21 |
| Albumin (g/L) | 37.89±4.56 |
| Globulin (g/L) | 32.35±5.99 |
| TB (μmol/L): median, range | 12.8 (4.7–159.05) |
| DB (μmol/L): median, range | 5.04 (1.83–128.99) |
| ALT (U/L) | 46.14±53.42 |
| AST (U/L) | 51.52±53.76 |
| ALP (U/L) | 99.50±70.59 |
| γ-GT (U/L): median, range | 63.4 (15.1–689.0) |
| HCLR level: median, range | 2.07 (0.01–32.8) |
Note:
a
Data presented as mean ± SD or others.
Abbreviations: γ-GT, γ-glutamyl transpeptidase; AFP, alpha-fetoprotein; ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; DB, direct bilirubin; HBsAg, hepatitis B surface antigen; HCLR, high-sensitivity C-reactive protein to lymphocyte ratio; LYMPH, lymphocyte count; TB, total bilirubin; WBC, white blood cell.